首页> 美国卫生研究院文献>Case Reports in Transplantation >Successful Renal Transplantation between Identical Twins with Very Brief Immunosuppression
【2h】

Successful Renal Transplantation between Identical Twins with Very Brief Immunosuppression

机译:在同卵双胞胎之间进行非常短暂的免疫抑制的成功肾移植

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Renal transplantation between monozygous identical twins provides an opportunity to utilize minimal immunosuppression to maintain stable allograft function, thereby alleviating the toxicities of immunosuppressive therapy. Despite monozygosity, there is a possibility of discordant protein presentation in identical twins that could trigger alloimmune response and lead to graft injury. Therefore, the optimal immunosuppression regimen in this patient population is unknown, and the safety of immunosuppression withdrawal remains controversial. Herein, we describe two patients who underwent successful renal transplantation from monozygotic identical twin donors. Monozygosity was determined using short tandem repeat (STR) analysis. All immunosuppression was successfully discontinued at 2 days and 3 weeks, respectively, after transplantation. Both patients are alive with functioning renal grafts at 1 year and 5 years after transplant, respectively. These two cases suggest that immunosuppression can be withdrawn safely and rapidly in select monozygous identical twin renal transplant recipients.
机译:单卵期同卵双胞胎之间的肾移植提供了利用最小的免疫抑制来维持稳定的同种异体移植功能的机会,从而减轻了免疫抑制疗法的毒性。尽管具有单合子性,但在同卵双胞胎中蛋白质表达不一致的可能性仍可能触发同种免疫反应并导致移植物损伤。因此,该患者人群的最佳免疫抑制方案尚不清楚,并且免疫抑制退出的安全性仍存在争议。在这里,我们描述了两名患者从同卵双生子同卵供体成功进行了肾移植。使用短串联重复序列(STR)分析确定单合性。移植后第2天和第3周分别成功终止所有免疫抑制。两名患者分别在移植后的1年和5年时都存活着功能正常的肾移植物。这两个案例表明,可以在选择的单合子同卵双肾移植受者中安全,快速地撤消免疫抑制作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号